Investigational Site

Liverpool, New South Wales 2170

0 studies enrolling now · 2 studies all time

What they study most

Anemia, CKD Anemia, Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

Studies at this site

• Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden — Stopped early
• A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis — Completed